Occupational Activity – Page 14

Insights from Jade CEO: Reverse Merger and IgAN Drug Development

6 months ago talkbio0Tagged biotech, CEO, Drug Development, IGA Glomerulonephritis, mergers, reverse merger

Jade CEO, Reverse Merger, IgAN Drugs, Pharmaceutical Development, Biotech Mergers

Biopharma Industry Alarmed by Prospect of RFK Jr. Shaping FDA Policies Under Trump Administration

6 months ago talkbio0Tagged Administration occupational activities, Agriculture, Biopharma, Health care facility, Policy, RFK Jr., Transplant Registry Unified Management Program, United States Food and Drug Administration

RFK Jr., FDA, Trump Administration, Biopharma, Healthcare Policy, Agriculture Policy

WuXi AppTec Faces Uncertainty Amid BIOSECURE Act, Yet Continues to Secure New Projects

6 months ago talkbio0Tagged AppTec, Biopharma, BIOSECURE, CDMOs, Contract agreement, Industry, Legislation, manufacturing organizations, National Security Concerns, Outsourcing, United States, WuXi

BIOSECURE Act, WuXi AppTec, Biotechnology Industry, U.S. Legislation, Contract Development and Manufacturing Organizations (CDMOs), Biopharma Outsourcing, National Security Concerns

Icon, Irish CRO Giant, Announces Layoffs Following Disappointing Q3 Performance

6 months ago talkbio0Tagged CRO, Icon brand of cyhalothrin, Industry, Irish (ethnic group), Performance

Icon, layoffs, Q3 performance, Irish CRO, biotech industry

GSK Invests $800 Million in Pennsylvania Site Expansion to Boost Vaccine and Medicine Production

6 months ago talkbio0Tagged expansion, Investments, Manufacturing, Pennsylvania, production, SmithKline Beecham, Vaccines

GSK, Pennsylvania, manufacturing expansion, vaccine production, medicine manufacturing, $800 million investment

Samsung Biologics Secures $1.2 Billion Production Contract, Boosting 2024 Deal Value to Over $3.3 Billion

6 months ago talkbio0Tagged Biological Factors, CDMO, Contract agreement, Deal Value, Manufacturing, production, Samsung

Samsung Biologics, CDMO, Contract Manufacturing, Biopharmaceuticals, Production Contract, 2024 Deal Value

Enhancing GI Tolerability of GLP-1 Receptor Agonists: A Path to Improved Therapeutic Outcomes

6 months ago talkbio0Tagged Administration occupational activities, agonists, Diabetes, gastrointestinal tolerability, GLP-1 receptor, Obesity, therapeutic strategies

GLP-1 receptor agonists, gastrointestinal tolerability, therapeutic strategies, diabetes management, obesity treatment

Sanofi Workers Strike Over Consumer Health Unit Sale Amid Job Loss and Strategic Asset Concerns

6 months ago talkbio0Tagged Clayton, consumer health unit, DOLIPRANE, France, losses, Opella, Sales - occupational activity, sanofi, strategic assets

Sanofi, strike, consumer health unit, sale, job losses, strategic assets, France, Doliprane, Opella, Clayton Dubilier & Rice

MeiraGTx’s Gene Therapy Shows Significant Improvements in Motor Function and Quality of Life in Parkinson’s Disease Trial

6 months ago talkbio0Tagged AAV-GAD, Clinical Trials, dopamine, gamma-aminobutyric acid, gene therapy, MeiraGTx, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Phase 2 trial, production, Quality of life, Surgical Replantation

MeiraGTx, Gene Therapy, Parkinson’s Disease, AAV-GAD, Motor Function, Quality of Life, Clinical Trial, Phase 2 Trial, Neurodegenerative Disease, Dopamine Replacement, GABA Production

WuXi AppTec and WuXi Biologics Consider Asset Sales Amid BIOSECURE Act Scrutiny

6 months ago talkbio0Tagged AppTec, asset, Biological Factors, BIOSECURE, Industry, Relations, Sales - occupational activity, U.S.-China, WuXi

WuXi AppTec, WuXi Biologics, BIOSECURE Act, asset sales, biotech industry, US-China relations